To explore the application value of high-frequency ultrasound combined with two-dimensional shear wave elastography (2D-SWE) in diagnosing low muscle mass in patients with cirrhosis.
Approach:
Study Design: 135 patients with cirrhosis were categorized into Cirrhosis and CRS groups based on Arm Skeletal Muscle Index (ASMI), with 66 healthy individuals as controls.
Data Collection: General characteristics, biochemical parameters, liver elastic modulus (LEM), muscle thickness (MT), and shear wave velocity (SWV) were analyzed.
Statistical Analysis: Pearson correlation and stepwise logistic regression were used to identify associations, and receiver operating characteristic curves were generated for diagnostic performance.
Key Findings:
CRS group showed lower MT and muscle SWV, but higher LEM compared to NC and cirrhosis groups (p < 0.05).
ASMI positively correlated with BMI, serum albumin, MT, and muscle SWV; negatively correlated with age, total bilirubin, LEM, and INR (all p < 0.05).
MG-SWV, RF-MT, and LEM were independently associated with CRS (all p < 0.05).
Combined application of muscle parameters and LEM had an AUC of 0.919, with sensitivity of 90.57% and specificity of 83.13%, outperforming single parameters.
Interpretation:
Ultrasound measurement of LEM, MT, and muscle SWV provides a diagnostic approach for CRS, with combined assessment enhancing diagnostic accuracy.
Limitations:
The study was conducted in a single tertiary hospital, which may limit generalizability.
The sample size may not capture all variations in cirrhotic patients.
Conclusion:
Ultrasound assessment of muscle metrics and liver stiffness may serve as a diagnostic tool for low muscle mass in cirrhotic patients.
Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.